Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2097 - 2104 of 11616 results
Green Deals Tripled Last Year Amid Emissions Crunch
March 21, 2022| News
Could A Bored Ape + CryptoPunk + ApeCoin = A Security?
March 18, 2022| Article| Viewpoint
Connecticut Proposal to Cap Drug Price Increases Could Portend a Shift in the Drug Pricing Debate
March 17, 2022| Blog| Viewpoint
The Department of Labor Addresses 401(k) Plan Investments in Cryptocurrencies
March 17, 2022| Blog| Viewpoint
Meet Healey’s New Campaign Manager
March 17, 2022| News
Healey Names Litigation Attorney Burrell As Campaign Manager
March 17, 2022| News
Utah Consumer Privacy Act – Mintz’s Hot Take
March 17, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.